199 related articles for article (PubMed ID: 37471281)
1. Retraction statement: Long non-coding RNA PGM5-AS1 promotes epithelial-mesenchymal transition, invasion and metastasis of osteosarcoma cells by impairing miR-140-5p-mediated FBN1 inhibition.
Mol Oncol; 2023 Aug; 17(8):1692. PubMed ID: 37471281
[TBL] [Abstract][Full Text] [Related]
2. Retraction Statement: Exosomal miR-1255b-5p targets human telomerase reverse transcriptase in colorectal cancer cells to suppress epithelial-to-mesenchymal transition.
Mol Oncol; 2023 Jul; 17(7):1454. PubMed ID: 37231586
[TBL] [Abstract][Full Text] [Related]
3. RETRACTION: The long noncoding RNA AK002107 negatively modulates miR-140-5p and targets TGFBR1 to induce epithelial-mesenchymal transition in hepatocellular carcinoma.
Mol Oncol; 2024 Jun; ():. PubMed ID: 38873938
[TBL] [Abstract][Full Text] [Related]
4. Retraction statement: Ding, J., Wang, X., Gao, J. and Song, T. (2021), Silencing of cystatin SN abrogates cancer progression and stem cell properties in papillary thyroid carcinoma. FEBS Open Bio, 11: 2186-2197.
FEBS Open Bio; 2023 Aug; 13(8):1540. PubMed ID: 37410095
[TBL] [Abstract][Full Text] [Related]
5. Retraction Statement: Circ-TCF4.85 silencing inhibits cancer progression through microRNA-486-5p-targeted inhibition of ABCF2 in hepatocellular carcinoma.
Mol Oncol; 2023 Jul; 17(7):1453. PubMed ID: 37231579
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA PGM5-AS1 promotes epithelial-mesenchymal transition, invasion and metastasis of osteosarcoma cells by impairing miR-140-5p-mediated FBN1 inhibition.
Liu W; Liu P; Gao H; Wang X; Yan M
Mol Oncol; 2020 Oct; 14(10):2660-2677. PubMed ID: 32412676
[TBL] [Abstract][Full Text] [Related]
7. Retraction: The long non-coding RNA-ROR promotes osteosarcoma progression by targeting miR-206.
J Cell Mol Med; 2024 Mar; 28(6):e18199. PubMed ID: 38439141
[TBL] [Abstract][Full Text] [Related]
8. Retraction: Wang C, Chen Z, Ge Q, Hu J, Li F, Hu J, Xu H, Ye Z, Li LC (2014) Up-regulation of p21
FEBS Lett; 2024 Jun; 598(11):1449. PubMed ID: 38747074
[TBL] [Abstract][Full Text] [Related]
9. Retraction statement: Wu, H., He, Y., Chen, H., Liu, Y., Wei, B., Chen, G., Lin, H. and Lin, H. (2019), LncRNA THOR increases osteosarcoma cell stemness and migration by enhancing SOX9 mRNA stability. FEBS Open Bio, 9: 781-790.
FEBS Open Bio; 2023 Aug; 13(8):1539. PubMed ID: 37219057
[TBL] [Abstract][Full Text] [Related]
10. Retraction statement: Long noncoding RNA MALAT1 promotes the stemness of esophageal squamous cell carcinoma by enhancing YAP transcriptional activity. FEBS Open Bio, 9: 1392-1402.
FEBS Open Bio; 2023 Nov; 13(11):2158. PubMed ID: 37792303
[TBL] [Abstract][Full Text] [Related]
11. Retraction statement: Shao, L., Zhang, X. and Yao, Q. (2020), The F-box protein FBXO11 restrains hepatocellular carcinoma stemness via promotion of ubiquitin-mediated degradation of Snail. FEBS Open Bio, 10: 1810-1820.
FEBS Open Bio; 2023 Aug; 13(8):1537. PubMed ID: 37219054
[TBL] [Abstract][Full Text] [Related]
12. Retraction statement: Dai, Y., Xie, F. and Chen, Y. (2020), Reduced levels of miR-485-5p in HPV-infected cervical cancer promote cell proliferation and enhance invasion ability. FEBS Open Bio, 10: 1348-1361.
FEBS Open Bio; 2023 Aug; 13(8):1538. PubMed ID: 37219053
[TBL] [Abstract][Full Text] [Related]
13. RETRACTION: MeCP2 Drives Hepatocellular Carcinoma Progression Via Enforcing HOXD3 Promoter Methylation and Expression Through the HB-EGF/EGFR Pathway.
Mol Oncol; 2024 Jun; ():. PubMed ID: 38837853
[TBL] [Abstract][Full Text] [Related]
14. Retraction: Kinesin family member 3A stimulates cell proliferation, migration, and invasion of bladder cancer cells in vitro and in vivo.
FEBS Open Bio; 2024 Mar; 14(3):528. PubMed ID: 38149473
[TBL] [Abstract][Full Text] [Related]
15. Retraction: p53 loses grip on PIK3CA expression leading to enhanced cell survival during platinum resistance.
Mol Oncol; 2024 Mar; 18(3):778. PubMed ID: 38439146
[TBL] [Abstract][Full Text] [Related]
16. Retraction statement: Yiwen Xiao, Jingjing Pan, Qian Geng, Ge Wang (2019), LncRNA MALAT1 increases the stemness of gastric cancer cells via enhancing SOX2 mRNA stability. FEBS Open Bio, 9: 1212-1222.
FEBS Open Bio; 2023 Sep; 13(10):1986. PubMed ID: 37724913
[TBL] [Abstract][Full Text] [Related]
17. Retraction.
Cancer Med; 2023 May; 12(9):11041. PubMed ID: 37050853
[TBL] [Abstract][Full Text] [Related]
18. Retraction: LINC01133 promotes the progression of cervical cancer via regulating miR-30a-5p/FOXD1.
Asia Pac J Clin Oncol; 2023 Dec; 19(6):762. PubMed ID: 37888963
[TBL] [Abstract][Full Text] [Related]
19. Retraction: miR-655 suppresses epithelial-to-mesenchymal transition by targeting Prrx1 in triple-negative breast cancer.
J Cell Mol Med; 2024 Apr; 28(8):e18314. PubMed ID: 38655709
[TBL] [Abstract][Full Text] [Related]
20. Retraction: Silencing of Prrx1b suppresses cellular proliferation, migration, invasion and epithelial-mesenchymal transition in triple-negative breast cancer.
J Cell Mol Med; 2024 Apr; 28(8):e18312. PubMed ID: 38661448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
